Boehringer Ingelheim to open $46 million biologics plant in Shanghai

The plant will be built under a strategic alliance with ZI Base in Pudong and focus on contract manufacturing to Chinese companies developing their own drugs.

China Industrial Biotech Network, June 10, 2013

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny